Human xenografts are not rejected in a naturally occurring immunodeficient porcine line

A human tumor model in pigs

Matthew T. Basel, Sivasai Balivada, Amanda P. Beck, Maureen A. Kerrigan, Marla M. Pyle, Jack C.M. Dekkers, Carol R. Wyatt, Robert R.R. Rowland, David E. Anderson, Stefan H. Bossmann, Deryl L. Troyer

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Animal models for cancer therapy are invaluable for preclinical testing of potential cancer treatments, however, therapies tested in such models often fail to translate into clinical settings. Therefore, a better preclinical model for cancer treatment testing is needed. Here we demonstrate that an immunodeficient line of pigs can host and support the growth of xenografted human tumors and has the potential to be an effective animal model for cancer therapy. Wild-type and immunodeficient pigs were injected subcutaneously in the left ear with human melanoma cells (A375SM cells) and in the right ear with human pancreatic carcinoma cells (PANC-1). All immunodeficient pigs developed tumors that were verified by histology and immunohistochemistry. Nonaffected littermates did not develop tumors. Immunodeficient pigs, which do not reject xenografted human tumors, have the potential to become an extremely useful animal model for cancer therapy because of their similarity in size, anatomy, and physiology to humans.

Original languageEnglish (US)
Pages (from-to)63-68
Number of pages6
JournalBioResearch Open Access
Volume1
Issue number2
DOIs
StatePublished - Jan 1 2012
Externally publishedYes

Fingerprint

Heterografts
Tumors
Swine
Animals
Oncology
Neoplasms
Animal Models
Histology
Physiology
Testing
Ear
Therapeutics
Cells
Melanoma
Anatomy
Immunohistochemistry
Growth

Keywords

  • Immunodeficient swine
  • Large-animal cancer model
  • Melanoma
  • Pancreatic carcinoma
  • Xenografts

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Human xenografts are not rejected in a naturally occurring immunodeficient porcine line : A human tumor model in pigs. / Basel, Matthew T.; Balivada, Sivasai; Beck, Amanda P.; Kerrigan, Maureen A.; Pyle, Marla M.; Dekkers, Jack C.M.; Wyatt, Carol R.; Rowland, Robert R.R.; Anderson, David E.; Bossmann, Stefan H.; Troyer, Deryl L.

In: BioResearch Open Access, Vol. 1, No. 2, 01.01.2012, p. 63-68.

Research output: Contribution to journalArticle

Basel, MT, Balivada, S, Beck, AP, Kerrigan, MA, Pyle, MM, Dekkers, JCM, Wyatt, CR, Rowland, RRR, Anderson, DE, Bossmann, SH & Troyer, DL 2012, 'Human xenografts are not rejected in a naturally occurring immunodeficient porcine line: A human tumor model in pigs', BioResearch Open Access, vol. 1, no. 2, pp. 63-68. https://doi.org/10.1089/biores.2012.9902
Basel, Matthew T. ; Balivada, Sivasai ; Beck, Amanda P. ; Kerrigan, Maureen A. ; Pyle, Marla M. ; Dekkers, Jack C.M. ; Wyatt, Carol R. ; Rowland, Robert R.R. ; Anderson, David E. ; Bossmann, Stefan H. ; Troyer, Deryl L. / Human xenografts are not rejected in a naturally occurring immunodeficient porcine line : A human tumor model in pigs. In: BioResearch Open Access. 2012 ; Vol. 1, No. 2. pp. 63-68.
@article{4e5e4991d99e4739b739e8dd24b6f468,
title = "Human xenografts are not rejected in a naturally occurring immunodeficient porcine line: A human tumor model in pigs",
abstract = "Animal models for cancer therapy are invaluable for preclinical testing of potential cancer treatments, however, therapies tested in such models often fail to translate into clinical settings. Therefore, a better preclinical model for cancer treatment testing is needed. Here we demonstrate that an immunodeficient line of pigs can host and support the growth of xenografted human tumors and has the potential to be an effective animal model for cancer therapy. Wild-type and immunodeficient pigs were injected subcutaneously in the left ear with human melanoma cells (A375SM cells) and in the right ear with human pancreatic carcinoma cells (PANC-1). All immunodeficient pigs developed tumors that were verified by histology and immunohistochemistry. Nonaffected littermates did not develop tumors. Immunodeficient pigs, which do not reject xenografted human tumors, have the potential to become an extremely useful animal model for cancer therapy because of their similarity in size, anatomy, and physiology to humans.",
keywords = "Immunodeficient swine, Large-animal cancer model, Melanoma, Pancreatic carcinoma, Xenografts",
author = "Basel, {Matthew T.} and Sivasai Balivada and Beck, {Amanda P.} and Kerrigan, {Maureen A.} and Pyle, {Marla M.} and Dekkers, {Jack C.M.} and Wyatt, {Carol R.} and Rowland, {Robert R.R.} and Anderson, {David E.} and Bossmann, {Stefan H.} and Troyer, {Deryl L.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1089/biores.2012.9902",
language = "English (US)",
volume = "1",
pages = "63--68",
journal = "BioResearch Open Access",
issn = "2164-7860",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - Human xenografts are not rejected in a naturally occurring immunodeficient porcine line

T2 - A human tumor model in pigs

AU - Basel, Matthew T.

AU - Balivada, Sivasai

AU - Beck, Amanda P.

AU - Kerrigan, Maureen A.

AU - Pyle, Marla M.

AU - Dekkers, Jack C.M.

AU - Wyatt, Carol R.

AU - Rowland, Robert R.R.

AU - Anderson, David E.

AU - Bossmann, Stefan H.

AU - Troyer, Deryl L.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Animal models for cancer therapy are invaluable for preclinical testing of potential cancer treatments, however, therapies tested in such models often fail to translate into clinical settings. Therefore, a better preclinical model for cancer treatment testing is needed. Here we demonstrate that an immunodeficient line of pigs can host and support the growth of xenografted human tumors and has the potential to be an effective animal model for cancer therapy. Wild-type and immunodeficient pigs were injected subcutaneously in the left ear with human melanoma cells (A375SM cells) and in the right ear with human pancreatic carcinoma cells (PANC-1). All immunodeficient pigs developed tumors that were verified by histology and immunohistochemistry. Nonaffected littermates did not develop tumors. Immunodeficient pigs, which do not reject xenografted human tumors, have the potential to become an extremely useful animal model for cancer therapy because of their similarity in size, anatomy, and physiology to humans.

AB - Animal models for cancer therapy are invaluable for preclinical testing of potential cancer treatments, however, therapies tested in such models often fail to translate into clinical settings. Therefore, a better preclinical model for cancer treatment testing is needed. Here we demonstrate that an immunodeficient line of pigs can host and support the growth of xenografted human tumors and has the potential to be an effective animal model for cancer therapy. Wild-type and immunodeficient pigs were injected subcutaneously in the left ear with human melanoma cells (A375SM cells) and in the right ear with human pancreatic carcinoma cells (PANC-1). All immunodeficient pigs developed tumors that were verified by histology and immunohistochemistry. Nonaffected littermates did not develop tumors. Immunodeficient pigs, which do not reject xenografted human tumors, have the potential to become an extremely useful animal model for cancer therapy because of their similarity in size, anatomy, and physiology to humans.

KW - Immunodeficient swine

KW - Large-animal cancer model

KW - Melanoma

KW - Pancreatic carcinoma

KW - Xenografts

UR - http://www.scopus.com/inward/record.url?scp=84901001448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901001448&partnerID=8YFLogxK

U2 - 10.1089/biores.2012.9902

DO - 10.1089/biores.2012.9902

M3 - Article

VL - 1

SP - 63

EP - 68

JO - BioResearch Open Access

JF - BioResearch Open Access

SN - 2164-7860

IS - 2

ER -